ALLIANCEBERNSTEIN L.P. - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 111 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q1 2022$96,000
-47.8%
34,600
+0.3%
0.00%
Q4 2021$184,000
-37.0%
34,5000.0%0.00%
Q3 2021$292,000
-30.6%
34,5000.0%0.00%
Q2 2021$421,000
+16.6%
34,500
+131.5%
0.00%
Q1 2021$361,000
-24.5%
14,9000.0%0.00%
Q4 2020$478,000
+10.6%
14,900
+4.2%
0.00%
Q3 2020$432,000
-32.2%
14,300
-5.3%
0.00%
Q2 2020$637,000
+186.9%
15,100
+69.7%
0.00%
Q1 2020$222,0008,9000.00%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q4 2020
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,449,845$110,568,0002.92%
Boxer Capital, LLC 2,014,858$64,576,0002.08%
RA Capital Management 2,589,904$83,006,0001.16%
Artal Group S.A. 1,646,517$52,771,0001.13%
Burrage Capital Management LLC 34,891$1,118,0000.85%
Bellevue Group AG 1,403,000$44,967,0000.52%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 802,511$25,720,0000.51%
Ikarian Capital, LLC 293,941$9,421,0000.42%
Avoro Capital Advisors LLC 640,000$20,512,0000.35%
Logos Global Management LP 123,465$3,957,0000.34%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders